SPAGO NANOMEDICAL

Spago Nanomedical is a Swedish nanomedicine company in clinical development phase with a proprietary platform of polymeric materials to bring more precise imaging diagnostics and treatment of life-threatening and debilitating diseases... Spago Nanomedical AB is a Swedish nanomedicines company in clinical development phase. The company´s development projects are based on a platform of polymeric materials with unique properties for more precise diagnosis and treatment of life-threatening and debilitating diseases... Our development projects, SpagoPix and Tumorad® have unique properties with potential to significantly improve healthcare for the benefit of patients. With SpagoPix, initial clinical data indicate that the candidate drug SN132D provides MRI-images with good contrast in breast tumors, the liver and the pancreas, without compromising safety. Improved precision in imaging increase chances of successful and cost-efficient treatment of patients. With Tumorad®, preclinical..

Also known as: Spago Nanomedical AB

Primary location: Lund Sweden